5-HT2C Receptors in the Basolateral Amygdala and Dorsal Striatum Are a Novel Target for the Anxiolytic and Antidepressant Effects of Exercise

PLoS ONE

Volumn 7, Issue 9, 2012, Pages

  Greenwood, Benjamin N ^a   Strong, Paul V ^a   Loughridge, Alice B ^a   Day, Heidi E W ^a   Clark, Peter J ^a   Mika, Agnieszka ^a   Hellwinkel, Justin E ^a   Spence, Katie G ^a   Fleshner, Monika ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CP 809101; MESSENGER RNA; SEROTONIN 2C AGONIST; SEROTONIN 2C RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANXIETY; ARTICLE; AVOIDANCE BEHAVIOR; BASOLATERAL AMYGDALA; BEHAVIOR CHANGE; CORPUS STRIATUM; DEPRESSION; EXERCISE TEST; FEAR; IN SITU HYBRIDIZATION; MALE; MENTAL HEALTH; NEUROPHYSIOLOGY; NONHUMAN; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN TARGETING; RAT; RECEPTOR DOWN REGULATION; AMYGDALOID NUCLEUS; ANIMAL; BRAIN; GENETICS; METABOLISM; PHYSIOLOGY; RANDOMIZATION;

RATTUS; RODENTIA;

AMYGDALA; ANIMALS; ANXIETY; BRAIN; DEPRESSION; IN SITU HYBRIDIZATION; MALE; PHYSICAL CONDITIONING, ANIMAL; RANDOM ALLOCATION; RATS; RECEPTOR, SEROTONIN, 5-HT2C;

EID: 84866644737     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0046118     Document Type: Article

References (89)

1. Strohle A, (2009) Physical activity, exercise, depression and anxiety disorders. J Neural Transm 116: 777-784.
2. Saeed SA, Antonacci DJ, Bloch RM, (2010) Exercise, yoga, and meditation for depressive and anxiety disorders. Am Fam Physician 81: 981-986.
3. Herring MP, O'Connor PJ, Dishman RK, (2010) The effect of exercise training on anxiety symptoms among patients: a systematic review. Arch Intern Med 170: 321-331.
4. Babyak M, Blumenthal JA, Herman S, Khatri P, Doraiswamy M, et al. (2000) Exercise treatment for major depression: maintenance of therapeutic benefit at 10 months. Psychosom Med 62: 633-638.
5. Binder E, Droste SK, Ohl F, Reul JM, (2004) Regular voluntary exercise reduces anxiety-related behaviour and impulsiveness in mice. Behav Brain Res 155: 197-206.
6. Fox JH, Hammack SE, Falls WA, (2008) Exercise is associated with reduction in the anxiogenic effect of mCPP on acoustic startle. Behav Neurosci 122: 943-948.
7. Greenwood BN, Foley TE, Burhans D, Maier SF, Fleshner M, (2005) The consequences of uncontrollable stress are sensitive to duration of prior wheel running. Brain Res 1033: 164-178.
8. Greenwood BN, Foley TE, Day HE, Campisi J, Hammack SH, et al. (2003) Freewheel running prevents learned helplessness/behavioral depression: role of dorsal raphe serotonergic neurons. J Neurosci 23: 2889-2898.
9. Greenwood BN, Strong PV, Brooks L, Fleshner M, (2008) Anxiety-like behaviors produced by acute fluoxetine administration in male Fischer 344 rats are prevented by prior exercise. Psychopharmacology (Berl) 199: 209-222.
10. Salam JN, Fox JH, Detroy EM, Guignon MH, Wohl DF, et al. (2009) Voluntary exercise in C57 mice is anxiolytic across several measures of anxiety. Behav Brain Res 197: 31-40.
11. Vollert C, Zagaar M, Hovatta I, Taneja M, Vu A, et al. (2011) Exercise prevents sleep deprivation-associated anxiety-like behavior in rats: potential role of oxidative stress mechanisms. Behav Brain Res 224: 233-240.
12. Duman CH, Schlesinger L, Russell DS, Duman RS, (2008) Voluntary exercise produces antidepressant and anxiolytic behavioral effects in mice. Brain Res.
13. Solberg LC, Horton TH, Turek FW, (1999) Circadian rhythms and depression: effect of exercise in an animal model. American Journal of Physiology 276: R152-R161.
14. Greenwood BN, Fleshner M, (2011) Exercise, stress resistance, and central serotonergic systems. Exercise and sport sciences reviews 39: 140-149.
15. Cotman CW, Berchtold NC, Christie LA, (2007) Exercise builds brain health: key roles of growth factor cascades and inflammation. Trends Neurosci 30: 464-472.
16. Ota KT, Duman RS, (2012) Environmental and pharmacological modulations of cellular plasticity: Role in the pathophysiology and treatment of depression. Neurobiology of disease.
17. Anderson IM, Mortimore C, (1999) 5-HT and human anxiety. Evidence from studies using acute tryptophan depletion. Adv Exp Med Biol 467: 43-55.
18. Graeff FG, (2004) Serotonin, the periaqueductal gray and panic. Neurosci Biobehav Rev 28: 239-259.
19. Graeff FG, Guimaraes FS, De Andrade TG, Deakin JF, (1996) Role of 5-HT in stress, anxiety, and depression. Pharmacol Biochem Behav 54: 129-141.
20. Graeff FG, Viana MB, Mora PO, (1997) Dual role of 5-HT in defense and anxiety. Neurosci Biobehav Rev 21: 791-799.
21. Ninan PT, (1999) The functional anatomy, neurochemistry, and pharmacology of anxiety. J Clin Psychiatry 60: 12-17.
22. Sharp T, Cowen PJ, (2011) 5-HT and depression: is the glass half-full? Current opinion in pharmacology 11: 45-51.
23. Owens MJ, Nemeroff CB, (1998) The serotonin transporter and depression. Depress Anxiety 8: 5-12.
24. Millan MJ, (2005) Serotonin 5-HT2C receptors as a target for the treatment of depressive and anxious states: focus on novel therapeutic strategies. Therapie 60: 441-460.
25. Millan MJ, (2003) The neurobiology and control of anxious states. Prog Neurobiol 70: 83-244.
26. Serretti A, Artioli P, De Ronchi D, (2004) The 5-HT2C receptor as a target for mood disorders. Expert Opin Ther Targets 8: 15-23.
27. Ribases M, Fernandez-Aranda F, Gratacos M, Mercader JM, Casasnovas C, et al. (2008) Contribution of the serotoninergic system to anxious and depressive traits that may be partially responsible for the phenotypical variability of bulimia nervosa. Journal of psychiatric research 42: 50-57.
28. Gardiner K, Du Y, (2006) A-to-I editing of the 5HT2C receptor and behaviour. Briefings in functional genomics & proteomics 5: 37-42.
29. Moreau JL, Bos M, Jenck F, Martin JR, Mortas P, et al. (1996) 5HT2C receptor agonists exhibit antidepressant-like properties in the anhedonia model of depression in rats. European neuropsychopharmacology: the journal of the European College of Neuropsychopharmacology 6: 169-175.
30. Millan MJ, Brocco M, Gobert A, Dekeyne A, (2005) Anxiolytic properties of agomelatine, an antidepressant with melatoninergic and serotonergic properties: role of 5-HT2C receptor blockade. Psychopharmacology (Berl) 177: 448-458.
31. Pjrek E, Winkler D, Konstantinidis A, Willeit M, Praschak-Rieder N, et al. (2007) Agomelatine in the treatment of seasonal affective disorder. Psychopharmacology (Berl) 190: 575-579.
32. Olie JP, Kasper S, (2007) Efficacy of agomelatine, a MT1/MT2 receptor agonist with 5-HT2C antagonistic properties, in major depressive disorder. Int J Neuropsychopharmacol 10: 661-673.
33. Stein DJ, Ahokas AA, de Bodinat C, (2008) Efficacy of agomelatine in generalized anxiety disorder: a randomized, double-blind, placebo-controlled study. J Clin Psychopharmacol 28: 561-566.
34. Gatch MB, (2003) Discriminative stimulus effects of m-chlorophenylpiperazine as a model of the role of serotonin receptors in anxiety. Life Sci 73: 1347-1367.
35. Murphy DL, Mueller EA, Hill JL, Tolliver TJ, Jacobsen FM, (1989) Comparative anxiogenic, neuroendocrine, and other physiologic effects of m-chlorophenylpiperazine given intravenously or orally to healthy volunteers. Psychopharmacology (Berl) 98: 275-282.
36. Van Veen JF, Van der Wee NJ, Fiselier J, Van Vliet IM, Westenberg HG, (2007) Behavioural effects of rapid intravenous administration of meta-chlorophenylpiperazine (m-CPP) in patients with generalized social anxiety disorder, panic disorder and healthy controls. Eur Neuropsychopharmacol 17: 637-642.
37. Charney DS, Woods SW, Goodman WK, Heninger GR, (1987) Serotonin function in anxiety. II. Effects of the serotonin agonist MCPP in panic disorder patients and healthy subjects. Psychopharmacology (Berl) 92: 14-24.
38. Campbell BM, Merchant KM, (2003) Serotonin 2C receptors within the basolateral amygdala induce acute fear-like responses in an open-field environment. Brain Res 993: 1-9.
39. Bagdy G, Graf M, Anheuer ZE, Modos EA, Kantor S, (2001) Anxiety-like effects induced by acute fluoxetine, sertraline or m-CPP treatment are reversed by pretreatment with the 5-HT2C receptor antagonist SB-242084 but not the 5-HT1A receptor antagonist WAY-100635. Int J Neuropsychopharmacol 4: 399-408.
40. Burghardt NS, Bush DE, McEwen BS, LeDoux JE, (2007) Acute selective serotonin reuptake inhibitors increase conditioned fear expression: blockade with a 5-HT(2C) receptor antagonist. Biol Psychiatry 62: 1111-1118.
41. Christianson JP, Ragole T, Amat J, Greenwood BN, Strong PV, et al. (2010) 5-hydroxytryptamine 2C receptors in the basolateral amygdala are involved in the expression of anxiety after uncontrollable traumatic stress. Biol Psychiatry 67: 339-345.
42. Cornelio AM, Nunes-de-Souza RL, (2007) Anxiogenic-like effects of mCPP microinfusions into the amygdala (but not dorsal or ventral hippocampus) in mice exposed to elevated plus-maze. Behav Brain Res 178: 82-89.
43. de Mello Cruz AP, Pinheiro G, Alves SH, Ferreira G, Mendes M, et al. (2005) Behavioral effects of systemically administered MK-212 are prevented by ritanserin microinfusion into the basolateral amygdala of rats exposed to the elevated plus-maze. Psychopharmacology (Berl) 182: 345-354.
44. Overstreet DH, Knapp DJ, Angel RA, Navarro M, Breese GR, (2006) Reduction in repeated ethanol-withdrawal-induced anxiety-like behavior by site-selective injections of 5-HT1A and 5-HT2C ligands. Psychopharmacology (Berl) 187: 1-12.
45. Strong PV, Christianson JP, Loughridge AB, Amat J, Maier SF, et al. (2011) 5-hydroxytryptamine 2C receptors in the dorsal striatum mediate stress-induced interference with negatively-reinforced instrumental escape behavior. Neuroscience.
46. Davis M, (1992) The role of the amygdala in fear and anxiety. Annu Rev Neurosci 15: 353-375.
47. LeDoux J, (2003) The emotional brain, fear, and the amygdala. Cell Mol Neurobiol 23: 727-738.
48. Sherman AD, Sacquitne JL, Petty F, (1982) Specificity of the learned helplessness model of depression. Pharmacol Biochem Behav 16: 449-454.
49. Christianson JP, Ragole T, Amat J, Greenwood BN, Strong PV, et al. (2010) 5-hydroxytryptamine 2C receptors in the basolateral amygdala are involved in the expression of anxiety after uncontrollable traumatic stress. Biological Psychiatry 67: 339-345.
50. Strong PV, Christianson JP, Loughridge AB, Amat J, Maier SF, et al. (2011) 5-hydroxytryptamine 2C receptors in the dorsal striatum mediate stress-induced interference with negatively reinforced instrumental escape behavior. Neuroscience 197: 132-144.
51. Englander MT, Dulawa SC, Bhansali P, Schmauss C, (2005) How stress and fluoxetine modulate serotonin 2C receptor pre-mRNA editing. The Journal of neuroscience: the official journal of the Society for Neuroscience 25: 648-651.
52. Barbon A, Orlandi C, La Via L, Caracciolo L, Tardito D, et al. (2011) Antidepressant treatments change 5-HT2C receptor mRNA expression in rat prefrontal/frontal cortex and hippocampus. Neuropsychobiology 63: 160-168.
53. Broocks A, Meyer T, George A, Hillmer-Vogel U, Meyer D, et al. (1999) Decreased neuroendocrine responses to meta-chlorophenylpiperazine (m-CPP) but normal responses to ipsapirone in marathon runners. Neuropsychopharmacology 20: 150-161.
54. Broocks A, Meyer T, Gleiter CH, Hillmer-Vogel U, George A, et al. (2001) Effect of aerobic exercise on behavioral and neuroendocrine responses to meta-chlorophenylpiperazine and to ipsapirone in untrained healthy subjects. Psychopharmacology (Berl) 155: 234-241.
55. Dwyer D, Browning J, (2000) Endurance training in Wistar rats decreases receptor sensitivity to a serotonin agonist. Acta Physiol Scand 170: 211-216.
56. Strong PV, Greenwood BN, Fleshner M, (2009) The effects of the selective 5-HT(2C) receptor antagonist SB 242084 on learned helplessness in male Fischer 344 rats. Psychopharmacology (Berl) 203: 665-675.
57. Atallah HE, Lopez-Paniagua D, Rudy JW, O'Reilly RC, (2007) Separate neural substrates for skill learning and performance in the ventral and dorsal striatum. Nat Neurosci 10: 126-131.
58. Paxinos G, Watson C. (1998) The Rat Brain in Stereotaxic Coordinates. New York: Academic Press.
59. Maier SF, (1990) Role of fear in mediating shuttle escape learning deficit produced by inescapable shock. J Exp Psychol Anim Behav Process 16: 137-149.
60. Fanselow M, Lester L (1988) A functional behavioristic approach to aversively motivated behavior: predatory imminence as a determinant of the topography of defensive behavior. In:Evolution and Learning; Bolles RC BM, editor. Hillsdale, NJ: Erlbaum. 185-212 p.
61. Maier SF, Watkins LR, (1998) Stressor Controllability, Anxiety, and Serotonin. Cognitive Therapy and Research 22: 595-613.
62. Greenwood BN, Foley TE, Day HE, Burhans D, Brooks L, et al. (2005) Wheel running alters serotonin (5-HT) transporter, 5-HT1A, 5-HT1B, and alpha 1b-adrenergic receptor mRNA in the rat raphe nuclei. Biol Psychiatry 57: 559-568.
63. Greenwood BN, Foley TE, Le TV, Strong PV, Loughridge AB, et al. (2011) Long-term voluntary wheel running is rewarding and produces plasticity in the mesolimbic reward pathway. Behav Brain Res 217: 354-362.
64. Salam JN, Fox JH, Detroy EM, Guignon MH, Wohl DF, et al. (2009) Voluntary exercise in C57 mice is anxiolytic across several measures of anxiety. Behavioural brain research 197: 31-40.
65. Greenwood BN, Loughridge AB, Sadaoui N, Christianson JP, Fleshner M, (2012) The protective effects of voluntary exercise against the behavioral consequences of uncontrollable stress persist despite an increase in anxiety following forced cessation of exercise. Behavioural brain research 233: 314-321.
66. Campeau S, Davis M, (1995) Involvement of the central nucleus and basolateral complex of the amygdala in fear conditioning measured with fear-potentiated startle in rats trained concurrently with auditory and visual conditioned stimuli. J Neurosci 15: 2301-2311.
67. Wilensky AE, Schafe GE, Kristensen MP, LeDoux JE, (2006) Rethinking the fear circuit: the central nucleus of the amygdala is required for the acquisition, consolidation, and expression of Pavlovian fear conditioning. J Neurosci 26: 12387-12396.
68. Li Q, Wichems CH, Ma L, Van de Kar LD, Garcia F, et al. (2003) Brain region-specific alterations of 5-HT2A and 5-HT2C receptors in serotonin transporter knockout mice. J Neurochem 84: 1256-1265.
69. Li Q, Luo T, Jiang X, Wang J, (2012) Anxiolytic effects of 5-HTA receptors and anxiogenic effects of 5-HTC receptors in the amygdala of mice. Neuropharmacology 62: 474-484.
70. Nestler EJ, Carlezon WA Jr, (2006) The mesolimbic dopamine reward circuit in depression. Biol Psychiatry 59: 1151-1159.
71. Hasler G, Fromm S, Carlson PJ, Luckenbaugh DA, Waldeck T, et al. (2008) Neural response to catecholamine depletion in unmedicated subjects with major depressive disorder in remission and healthy subjects. Archives of general psychiatry 65: 521-531.
72. Lex B, Hauber W, (2010) The role of dopamine in the prelimbic cortex and the dorsomedial striatum in instrumental conditioning. Cerebral cortex 20: 873-883.
73. Alex KD, Yavanian GJ, McFarlane HG, Pluto CP, Pehek EA, (2005) Modulation of dopamine release by striatal 5-HT2C receptors. Synapse 55: 242-251.
74. Dishman RK, Renner KJ, Youngstedt SD, Reigle TG, Bunnell BN, et al. (1997) Activity wheel running reduces escape latency and alters brain monoamine levels after footshock. Brain research bulletin 42: 399-406.
75. Eberle-Wang K, Mikeladze Z, Uryu K, Chesselet MF, (1997) Pattern of expression of the serotonin2C receptor messenger RNA in the basal ganglia of adult rats. The Journal of comparative neurology 384: 233-247.
76. Lovinger DM, (2010) Neurotransmitter roles in synaptic modulation, plasticity and learning in the dorsal striatum. Neuropharmacology 58: 951-961.
77. Balleine BW, Liljeholm M, Ostlund SB, (2009) The integrative function of the basal ganglia in instrumental conditioning. Behav Brain Res 199: 43-52.
78. Wang Q, O'Brien PJ, Chen CX, Cho DS, Murray JM, et al. (2000) Altered G protein-coupling functions of RNA editing isoform and splicing variant serotonin2C receptors. J Neurochem 74: 1290-1300.
79. Burns CM, Chu H, Rueter SM, Hutchinson LK, Canton H, et al. (1997) Regulation of serotonin-2C receptor G-protein coupling by RNA editing. Nature 387: 303-308.
80. Niswender CM, Copeland SC, Herrick-Davis K, Emeson RB, Sanders-Bush E, (1999) RNA editing of the human serotonin 5-hydroxytryptamine 2C receptor silences constitutive activity. J Biol Chem 274: 9472-9478.
81. Herrick-Davis K, Grinde E, Niswender CM, (1999) Serotonin 5-HT2C receptor RNA editing alters receptor basal activity: implications for serotonergic signal transduction. J Neurochem 73: 1711-1717.
82. Price RD, Sanders-Bush E, (2000) RNA editing of the human serotonin 5-HT(2C) receptor delays agonist-stimulated calcium release. Mol Pharmacol 58: 859-862.
83. Berg KA, Clarke WP, Cunningham KA, Spampinato U, (2008) Fine-tuning serotonin2c receptor function in the brain: molecular and functional implications. Neuropharmacology 55: 969-976.
84. Iwamoto K, Bundo M, Kato T, (2009) Serotonin receptor 2C and mental disorders: genetic, expression and RNA editing studies. RNA Biol 6: 248-253.
85. Gurevich I, Tamir H, Arango V, Dwork AJ, Mann JJ, et al. (2002) Altered editing of serotonin 2C receptor pre-mRNA in the prefrontal cortex of depressed suicide victims. Neuron 34: 349-356.
86. Gardiner K, Du Y, (2006) A-to-I editing of the 5HT2C receptor and behaviour. Brief Funct Genomic Proteomic 5: 37-42.
87. Gurevich I, Englander MT, Adlersberg M, Siegal NB, Schmauss C, (2002) Modulation of serotonin 2C receptor editing by sustained changes in serotonergic neurotransmission. J Neurosci 22: 10529-10532.
88. Moya PR, Fox MA, Jensen CL, Laporte JL, French HT, et al. (2011) Altered 5-HT2C receptor agonist-induced responses and 5-HT2C receptor RNA editing in the amygdala of serotonin transporter knockout mice. BMC Pharmacol 11: 3.
89. Davis JM, Bailey SP, (1997) Possible mechanisms of central nervous system fatigue during exercise. Med Sci Sports Exerc 29: 45-57.